Alx Oncology Holdings (ALXO) Free Cash Flow (2019 - 2026)

Alx Oncology Holdings has reported Free Cash Flow for 8 years, with the latest figure at -$18.7 million in Q1 2026.

• Quarterly Free Cash Flow rose 24.37% year-over-year to -$18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78.3 million (up 28.15% YoY) and the FY2025 annual result came in at -$84.4 million, up 31.06% from the prior year.
• Free Cash Flow rose to -$18.7 million in Q1 2026 per ALXO's latest filing, from -$19.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$17.1 million in Q3 2025 and troughed at -$39.8 million in Q4 2023.
• A 5-year average of -$26.3 million and a median of -$25.5 million in 2024 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 313.52% in 2022, then soared 40.73% in 2025.
• Over 5 years, Free Cash Flow stood at -$21.2 million in 2022, then sank by 87.69% to -$39.8 million in 2023, then increased by 19.38% to -$32.1 million in 2024, then jumped by 40.73% to -$19.0 million in 2025, then grew by 1.74% to -$18.7 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$18.7 million, -$19.0 million, and -$17.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.